Summary of Significant Accounting Policies (Tables)

9 Months Ended

Jun. 30, 2024

Schedule of Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.


	June 30, 2024		June 30, 2023
Cash and cash equivalents	$	183	$	260
Restricted cash	28		78
Cash, cash equivalents and restricted cash	$	211	$	338

Schedule of Cash and Cash Equivalents


	June 30, 2024		June 30, 2023
Cash and cash equivalents	$	183	$	260
Restricted cash	28		78
Cash, cash equivalents and restricted cash	$	211	$	338

Schedule of Shares Used in Computing Basic and Diluted Earnings Per Share

Shares used in computing basic and diluted earnings per share are as follows:


	Three Months Ended June 30,		Nine Months Ended June 30,
	2024	2023	2024	2023
Denominator (thousands of shares):
Weighted-average common shares outstanding — basic	210,679	209,706	210,090	209,811
Incremental shares issuable for stock options, common stock awards and Equity Units (a)(b)	—	—	5,128	—
Weighted-average common shares outstanding — diluted	210,679	209,706	215,218	209,811

(a)For the three months ended June 30, 2024 and 2023 and for the nine months ended June 30, 2023, 3,823, 5,972, and 6,222 shares, respectively, have been excluded from the computation of diluted earnings per share as such incremental shares would be antidilutive due to the net losses for the periods. For the nine months ended June 30, 2024, 8,487 shares associated with outstanding stock option awards were excluded from the computation of diluted earnings per share because their effect was antidilutive.

(b)The Equity Units were settled in June 2024. See “Equity Units” below for additional information.